Device Trial Radar · NCT03382652
Continuum™ Metal Bearing System in Total Hip Arthroplasty
Last checked: Nov 21, 2026Latest source record: Jan 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
83
Actual
Start
Feb 9, 2011
Primary completion
Oct 22, 2022
Study completion Oct 22, 2022
Sponsor
- Lead sponsor
- Zimmer BiometPublic (ZBH)
- Sponsor type
- Industry
- First posted
- Dec 26, 2017
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is a multi-center, prospective, non-controlled, consecutive cohort post market surveillance study. The objective of this study is to obtain survival and outcome data on the Continuum Metal Bearing System in primary total hip arthroplasty.
Conditions
- Avascular Necrosis
- Osteoarthritis
- Inflammatory Arthritis
- Post-traumatic; Arthrosis
- Total Hip Arthroplasty
Interventions
Metal-on-Metal ArticulationDevice
\<Metal-on-Metal Articulation\>: Metasul® Taper Liner and Metasul Femoral Head, \<Acetabular Component\>:Continuum Acetabular Shell, \<Femoral Component\>: Zimmer® M/L Taper Hip Stem
Primary outcomes
What the sponsor says the trial is designed to measure.
- Implant Survival at 10 YearsTime frame: 1, 2, 3, 5, 7, and 10 years postop.
Locations
3 sites in 2 countries. Site status is shown where the registry gives one.
Saint Davids Medical Center
Austin, Texas
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.